Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors

Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors

US Patent 9382255 · Granted Jul 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseas2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseas2025
Dihydrooxadiazinones2025
Dihydrooxadiazinones2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Macrocyclic fluorine substituted indole derivatives2024
Compounds, compositions and methods for cancer patient stratification and cancer2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation2024